Dane E. Karr

2.4k citations

29 papers · 1.5k indexed · h-index 18

Impact in

Spectroscopy top 2%
- Mass Spectrometry Techniques and Applications
- Analytical Chemistry and Chromatography
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in ⓘ

Genetics 7
- Chronic Lymphocytic Leukemia Research 6
Analytical Chemistry 6
- Analytical chemistry methods development 6

Co-authors: Paul O. Danis (6 shared papers)Donald E. Schmidt (5 shared papers)Robert Cass (3 shared papers)Clifford H. Watson (1 shared paper)Franz J. Mayer (1 shared paper)A. Holle (1 shared paper)Kevin M. Krause (2 shared papers)C W Moss (3 shared papers)
Journals: Rapid Communications in Mass Spectrometry (4 papers)Journal of Clinical Microbiology (4 papers)Macromolecules (3 papers)Annals of the Rheumatic Diseases (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)
Partner nations: United States Australia Canada

In The Last Decade

Dane E. Karr

29 papers receiving 1.4k citations

Peers

Countries citing papers authored by Dane E. Karr

Since Specialization

Citations

This map shows the geographic impact of Dane E. Karr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dane E. Karr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dane E. Karr more than expected).

Fields of papers citing papers by Dane E. Karr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dane E. Karr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dane E. Karr. The network helps show where Dane E. Karr may publish in the future.

Co-authors

The 25 scholars most cited alongside Dane E. Karr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dane E. Karr Line = papers co-authored together Dane E. Karr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy ·Deborah L. Higgins, Ray Chang, Dmitri Debabov, Joey Leung, Terry X. Wu, Kevin M. Krause, Erik Sandvik, Jeffrey M. Hubbard, Koné Kaniga, Donald E. Schmidt, Qiufeng Gao, Robert Cass, Dane E. Karr, Bret M. Benton, P.P.A. Humphrey	2005	356
2	The analysis of water‐soluble polymers by matrix‐assisted laser desorption time‐of‐flight mass spectrometry Organic Mass Spectrometry ·Paul O. Danis, Dane E. Karr, Franz J. Mayer, A. Holle, Clifford H. Watson	1992	170
3	A facile sample preparation for the analysis of synthetic organic polymers by matrix‐assisted laser desorption/ionization Organic Mass Spectrometry ·Paul O. Danis, Dane E. Karr	1993	150
4	Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424) The Journal of Antibiotics ·Michael R. Leadbetter, Stacy M. Adams, BETTINA BAZZINI, Paul R. Fatheree, Dane E. Karr, Kevin M. Krause, Bernice M. T. Lam, Martin S. Linsell, Matthew B. Nodwell, John Pace, Kelly L. Quast, Jeng‐Pyng Shaw, ELIZABETH SORIANO, Sean Trapp, Jenny D. Villena, Terry X. Wu, B. G. CHRISTENSEN, J. Kevin Judice	2004	126
5	Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors Journal of Medicinal Chemistry ·Ken A. Brameld, Timothy D. Owens, Erik Verner, Eleni Venetsanakos, J. Michael Bradshaw, Vernon T. Phan, Danny Tam, Kwan Keung Leung, Jin Shu, Jacob LaStant, David G. Loughhead, Tony Ton, Dane E. Karr, Mary E. Gerritsen, David Goldstein, Jens Oliver Funk	2017	84
6	Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Characterization of Poly(butyl methacrylate) Synthesized by Group-Transfer Polymerization Macromolecules ·Paul O. Danis, Dane E. Karr, William J. Simonsick, Dejun Wu	1995	76
7	A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers British Journal of Clinical Pharmacology ·Patrick F. Smith, Janakan Krishnarajah, Philip A. Nunn, Ron J. Hill, Dane E. Karr, Danny Tam, Mohammad R. Masjedizadeh, Jens Oliver Funk, Steve G. Gourlay	2017	76
8	Rapid bioanalysis of vancomycin in serum and urine by high‐performance liquid chromatography tandem mass spectrometry using on‐line sample extraction and parallel analytical columns Rapid Communications in Mass Spectrometry ·Robert Cass, Josephine S. Villa, Dane E. Karr, Donald E. Schmidt	2001	61
9	Methods for the Analysis of Hydrocarbon Polymers by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Rapid Communications in Mass Spectrometry ·Paul O. Danis, Dane E. Karr, Yansan Xiong, Kevin G. Owens	1996	48
10	Isoprenoid quinones of the genus Legionella Journal of Clinical Microbiology ·Dane E. Karr, W F Bibb, C W Moss	1982	48
11	Measurement of propagation rate coefficients using pulsed-laser polymerization and matrix-assisted laser desorption/ionization mass spectrometry Macromolecules ·Paul O. Danis, Dane E. Karr, David G. Westmoreland, Mark C. Piton, David I. Christie, Paul A. Clay, Scott H. Kable, Robert G. Gilbert	1993	41
12	Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168) Clinical and Translational Science ·Timothy D. Owens, Patrick F. Smith, Andrew Redfern, Yan Xing, Jin Shu, Dane E. Karr, Sonja Hartmann, Michelle Francesco, Claire L. Langrish, Philip A. Nunn, Steven G. Gourlay	2021	36
13	Nx-5948, a Selective Degrader of BTK with Activity in Preclinical Models of Hematologic and Brain Malignancies Blood ·Daniel Robbins, Mark Noviski, Ryan B. Rountree, May Tan, Nivetha Brathaban, Timothy Ingallinera, Dane E. Karr, Aileen Kelly, Zef Konst, Jun Ma, Austin Tenn-McClellan, Jenny McKinnell, Luz Perez, Cristiana Guiducci, Gwenn M. Hansen, Arthur Sands	2021	35
14	Analysis of Poly(styrenesulfonic acid) by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Macromolecules ·Paul O. Danis, Dane E. Karr	1995	26
15	Cellular fatty acid composition and ubiquinone content of Legionella feeleii sp. nov Journal of Clinical Microbiology ·C W Moss, W F Bibb, Dane E. Karr, G O Guerrant, M A Lambert	1983	25
16	The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance Molecular Cancer Therapeutics ·Eleni Venetsanakos, Ken A. Brameld, Vernon T. Phan, Erik Verner, Timothy D. Owens, Yan Xing, Danny Tam, Jacob LaStant, Kwan Keung Leung, Dane E. Karr, Ronald J. Hill, Mary E. Gerritsen, David Goldstein, Jens Oliver Funk, J. Michael Bradshaw	2017	22
17	Cellular Fatty Acid Composition of Legionella longbeachae sp. nov Journal of Clinical Microbiology ·C. Wayne Moss, Dane E. Karr, S B Dees	1981	22
18	Cellular fatty acids of Capnocytophaga species Journal of Clinical Microbiology ·S B Dees, Dane E. Karr, D G Hollis, C W Moss	1982	18
19	PRN1008, a Reversible Covalent BTK Inhibitor in Clinical Development for Immune Thrombocytopenic Purpura Blood ·Claire L. Langrish, J. Michael Bradshaw, Timothy D. Owens, Robert L. Campbell, Michelle Francesco, Dane E. Karr, Steve K Murray, Robert C Quesenberry, Patrick F. Smith, Michael D. Taylor, Jiang Zhu, Philip A. Nunn, Steven G. Gourlay	2017	15
20	SAT0232 A Phase 1 Clinical Trial of PRN1008, an Oral, Reversible, Covalent BTK Inhibitor Demonstrates Clinical Safety and Therapeutic Levels of BTK Occupancy Without Sustained Systemic Exposure Annals of the Rheumatic Diseases ·Patrick F. Smith, Janakan Krishnarajah, P.A. Nunn, Ronald J. Hill, Dane E. Karr, Danny Tam, Mohammad R. Masjedizadeh, Steven G. Gourlay	2015	8

About Dane E. Karr

Dane E. Karr is a scholar working on Genetics, Analytical Chemistry, Spectroscopy, Endocrinology and Hematology, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Mass Spectrometry Techniques and Applications (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Analytical chemistry methods development (6 papers), Analytical Chemistry and Chromatography (5 papers), Advanced Chemical Sensor Technologies (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Legionella and Acanthamoeba research (3 papers). The work is most often cited by research in Spectroscopy (483 citations), Molecular Medicine (117 citations), Analytical Chemistry (185 citations), Microbiology (111 citations) and Infectious Diseases (317 citations). Dane E. Karr has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Paul O. Danis, Donald E. Schmidt, Robert Cass, Clifford H. Watson, Franz J. Mayer, A. Holle, Kevin M. Krause, C W Moss, Deborah L. Higgins and Dmitri Debabov. Their work appears in journals such as Rapid Communications in Mass Spectrometry, Journal of Clinical Microbiology, Macromolecules, Annals of the Rheumatic Diseases and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact